Skip to main content

A leading global Testing, Inspection & Certification Group

ALS (ALQ) is a global Testing, Inspection and Certification (TIC) company, servicing clients across several industries. ALQ commands a market-leading position in geochemical testing, leveraging its hub-and-spoke model, Laboratory Information Management System (LIMS) and innovative value-added capabilities. In Life Sciences, ALQ operates one of the largest global environmental testing businesses, with a footprint spanning 35+ countries. The company’s Pharmaceutical division aims to establish regional leadership in key geographies including Western Europe, delivering Contract Research Organisation (CRO) services, Beauty and Cosmetics claims testing and batch release testing. ALQ’s food testing division services clients across the food value chain from farm to food retailer, predominantly in Western Europe.

Tracking ahead of FY27 targets

We forecast 8.5% EPS CAGR over FY24-27, with revenue and EBIT tracking ahead of the company’s FY27 targets ($3.3b and $0.6b, respectively). This outlook is underpinned by: (1) a recovery in exploration testing sample volume growth from FY26 and further take-up of higher margin, value-added services; (2) high single-digit organic revenue growth in Environmental driven by increased penetration and regulation in traditional markets and rapid growth in PFAS testing demand in the USA and key markets in Europe; (3) further business development success at Nuvisan and ongoing progression of the €25m (~A$43m) cost-out program (>50% complete), delivering significant profitability improvements by FY26; (4) greater demand for CRO services in Europe once the BIOSECURE Act is legislated in the USA; and (5) further scope growth in the Life Sciences segment through programmatic acquisitions.

Investment thesis: Initiate with Buy; TP$17.30/sh

We see compelling value in ALQ as an investment leveraged to increasing societal demands for green environmental testing practices, stringent enforcement of PFAS remediation and monitoring programs and a recovery in global exploration testing volumes and regional (European) CRO activity. ALQ should continue to create value through its targeted capital allocation framework, delivering >15% ROCE.

To read the full report click the button below.

View Detailed Report
Authored by Joseph House – Analyst – at Bell Potter Securities, 03 December 2024
Important Disclaimer—This may affect your legal rights: Because this document has been prepared without consideration of any specific client’s financial situation, particular needs and investment objectives, a Bell Potter Securities Limited investment adviser (or the financial services licensee, or the proper authority of such licensee, who has provided you with this report by arrangement with Bell Potter Securities Limited) should be consulted before any investment decision is made. While this document is based on the information from sources which are considered reliable, Bell Potter Securities Limited, its directors, employees and consultants do not represent, warrant or guarantee, expressly or impliedly, that the information contained in this document is complete or accurate. Nor does Bell Potter Securities Limited accept any responsibility to inform you of any matter that subsequently comes to its notice, which may affect any of the information contained in this document. This document is a private communication to clients and is not intended for public circulation or for the use of any third party, without the prior approval of Bell Potter Securities Limited. In the USA and the UK this research is only for institutional investors. It is not for release, publication or distribution in whole or in part to any persons in the two specified countries. This is general investment advice only and does not constitute advice to any person.
Disclosure of Interest: Bell Potter Securities Limited receives commission from dealing in securities and its authorised representatives, or introducers of business, may directly share in this commission. Bell Potter Securities and its associates may hold shares in the companies recommended.